Barclays analyst Matt Miksic maintained a Buy rating on Baxter International (BAX – Research Report) on March 7 and set a price target of ...

Clinical teams working in hospitals are constantly on the move, keeping up with urgent demands in a fast-paced environment. | ...

Barclays raised the firm’s price target on Baxter (BAX) to $41 from $39 and keeps an Overweight rating on the shares. The firm updated its ...

Shares of Baxter International Inc. BAX slid 4.02% to $34.41 Wednesday, on what proved to be an all-around mixed trading ...

The Food and Drug Administration March 5 announced that Baxter Healthcare Corporation recalled its Spectrum infusion pumps ...

Baxter International recently launched the Voalte Linq device, a voice-activated communication tool for healthcare environments, which aligns with their strategy to enhance connectivity in care ...

Baxter Healthcare has issued a recall for some Spectrum infusion pumps due to a potential defect involving missing motor mounting screws, which could lead to interruptions, delays or incorrect ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025. Joel Grade, Baxter’s chief ...

Slamdance is nearing the final day of its 2025 edition, a historic one for the festival founded in 1995 as a scrappy alternative to Sundance. The cinematic showcase has made a new home for itself ...

DEERFIELD, Ill., February 18, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45 th Annual Health Care Conference on Wednesday ...

Labor said Baxter Healthcare, the only local manufacturer of IV fluids, will match the government’s investment, which will increase its annual production by at least 20 million units to 80 ...